Saturday, 31 October 2026European Markets

VERIMATRIX Stock Bullish Momentum With A 11.16% Rise Today

Loading stream...

(vianews) - the market ended the session with verimatrix (vmx.pa) jumping 11.16% to €0.71 on tuesday, after three successive sessions in a row of gains. cac 40 jumped 0.47% to €7,533.63, following the last session's downward trend on what was a somewhat bullish trend trading session today.

about verimatrix

verimatrix sa provides security solutions that protect digital content, applications, and devices worldwide. it offers anti-piracy products, including streamkeeper pro, which safeguards the ott content distribution ecosystem by disrupting pirate revenue streams; streamkeeper multi-drm that offers secure content on any screen or platform; streamkeeper watermarking, which protects content with invisible client and server-side watermarking that can detect piracy; high bandwidth digital content protection (hdcp) and digital trasmission content protection (dtcp), a solution for content protection for consumer electronics; and video content authority system (vcas) for evolving networks. the company also provides threat defense solutions, such as app shield that secures android and ios apps; code shield, which secures code with an enterprise-grade security toolkit; key shield, that protects algorithm and builds secure cryptographic architectures; and extended threat defense, a cybersecurity solution. it offers security solutions for various markets comprising automotive, e-sports and gaming, financial services, healthcare, internet of things, live sports, media and entertainment, pay tv, and stream media, as well as for content owners. the company was formerly known as inside secure s.a. and changed its name to verimatrix sa in july 2017. verimatrix sa was incorporated in 1995 and is based in meyreuil, france.

earnings per share

as for profitability, verimatrix has a trailing twelve months eps of €-0.14.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, verimatrix's stock is considered to be oversold (<=20).

volatility

verimatrix's last week, last month's, and last quarter's current intraday variation average was 0.99%, 0.22%, and 2.40%.

verimatrix's highest amplitude of average volatility was 1.73% (last week), 1.31% (last month), and 2.40% (last quarter).

volume

today's last reported volume for verimatrix is 219361 which is 163.41% above its average volume of 83276.

more news about verimatrix (vmx.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com